- Home
- CCEL vs SWAG Comparison
CCEL vs SWAG Comparison
Compare CCEL & SWAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- SWAG
- Stock Information
- Founded
- CCEL 1989
- SWAG 1994
- Country
- CCEL United States
- SWAG United States
- Employees
- CCEL N/A
- SWAG N/A
- Industry
- CCEL Managed Health Care
- SWAG Advertising
- Sector
- CCEL Health Care
- SWAG Consumer Discretionary
- Exchange
- CCEL Nasdaq
- SWAG Nasdaq
- Market Cap
- CCEL 34.8M
- SWAG 31.2M
- IPO Year
- CCEL 1997
- SWAG 2021
- Fundamental
- Price
- CCEL $4.53
- SWAG $1.75
- Analyst Decision
- CCEL Strong Buy
- SWAG
- Analyst Count
- CCEL 1
- SWAG 0
- Target Price
- CCEL $8.50
- SWAG N/A
- AVG Volume (30 Days)
- CCEL 24.9K
- SWAG 76.0K
- Earning Date
- CCEL 10-15-2025
- SWAG 11-06-2025
- Dividend Yield
- CCEL 13.22%
- SWAG N/A
- EPS Growth
- CCEL N/A
- SWAG N/A
- EPS
- CCEL N/A
- SWAG N/A
- Revenue
- CCEL $31,988,783.00
- SWAG $108,405,000.00
- Revenue This Year
- CCEL $1.75
- SWAG N/A
- Revenue Next Year
- CCEL N/A
- SWAG N/A
- P/E Ratio
- CCEL N/A
- SWAG N/A
- Revenue Growth
- CCEL 1.10
- SWAG 38.74
- 52 Week Low
- CCEL $4.09
- SWAG $0.73
- 52 Week High
- CCEL $9.43
- SWAG $1.96
- Technical
- Relative Strength Index (RSI)
- CCEL 45.10
- SWAG 51.46
- Support Level
- CCEL $4.51
- SWAG $1.53
- Resistance Level
- CCEL $4.93
- SWAG $1.80
- Average True Range (ATR)
- CCEL 0.14
- SWAG 0.11
- MACD
- CCEL -0.02
- SWAG -0.02
- Stochastic Oscillator
- CCEL 36.00
- SWAG 52.27
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About SWAG Stran & Company Inc.
Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.